The Adelaide Investigator Academy
The NHMRC Investigator Grant scheme recognises 最新糖心Vlog鈥檚 most outstanding medical research leaders and emerging leaders. Recipients are supported by the Commonwealth government to undertake ambitious research programs for 5 years.
The Adelaide Investigator Academy hosts these distinguished 最新糖心Vlog of Adelaide researchers who have made world-class impact over the course of their careers, and emerging leaders who are recognised among 最新糖心Vlog鈥檚 brightest early and mid-career research talents.
Leadership 3, 2022-2026
Restoring the Fair Go: which policies and practices are likely to reverse growing health inequities in 最新糖心Vlog post COVID-19.
Leadership 3, 2020-2024
Gastric emptying, glucagon-like peptide-1 and glycaemic control in diabetes and critical illness.
Leadership 3, 2022-2026
A curative approach for chronic myeloid leukaemia.
Leadership 3, 2023-2027
N-3 (Omega-3) Precision Nutrition: Preventing prematurity and enhancing cognitive development of very preterm children.
Leadership 3, 2020-2024
Understanding and preventing pneumococcal disease.
Leadership 2, 2021-2025
Healthy diet and weight management in pregnancy: evidence to ease a hefty clinical burden.
Leadership 2, 2022-2026
Advancing Indigenous 最新糖心Vlogn Oral health through clinical trials, cohort studies and surveillance.
Leadership 2, 2025-2029
Novel Strategies for Global Control of Meningococcal Disease and Gonorrhoea.
Leadership 2, 2025-2029
Exploring the Boundaries of Nuclear Reprogramming.
Leadership 2, 2021-2025, NHMRC Elizabeth Blackburn Investigator Grant Award
Peri-conception determinants of reproductive and pregnancy health.
Leadership 2, 2023-2027
Managing the First Pillar for Atrial Fibrillation and Stroke.
Leadership 2, 2021-2025
From bench to bedside: A new treatment for chronic rhinosinusitis.
Leadership 1, 2022-2026
Novel nanotechnology strategies towards a new paradigm of precision nanomedicine.
Leadership 1, 2025-2029
Supporting Neurodevelopment through Targeted Nutrition.
Leadership 1, 2026-2030
Advancing the Science of Evidence Synthesis: Developing Standards, Guidance and Resources for Better Evidence for Better Health Decisions.聽
Emerging Leadership 2, 2022-2026
Addressing evidence gaps to improve adolescent sexual and reproductive health.
Professor Philippa Middleton
Emerging Leadership 2, 2020-2024
Implementing nutrition and lifestyle interventions for women, young children and families.
Emerging Leadership 2, 2025-2029
Harnessing the Gut Microbiota to Predict and Prevent Life-Threatening Complications of Blood Cancer Treatment.
Emerging Leadership 2, 2024-2028
New approaches to the prevention and management of heart rhythm disorders.
Emerging Leadership 2, 2021-2025
Driving advances in sugar-sweetened beverage policy and resolving the unknown substitution effects into artificially sweetened beverage, fruit juice and water consumption.
Emerging Leadership 1, 2022-2026
Developing Genetic Testing Tools for Optimising Pharmacotherapy and Enabling a Precision Mental Health Care.
Emerging Leadership 1, 2025-2029
Studying the Topology of Cancer Tissue and its Microenvironment to Identify Topological Biomarkers.
Emerging Leadership 1, 2020-2024
Improving wellbeing and preventing lateral violence in the Aboriginal community in SA: Investing in our young.
Doctor Roula Ghaoui
Emerging Leadership 1, 2021-2025
Diagnosing hereditary myopathies and dystrophies with RNA sequencing: translating research innovations into diagnostic practice.
Emerging Leadership 1, 2024-2028
A conductive hydrogel-based cardiac patch integrated with bioelectronics for repairing infarcted myocardium.
Emerging Leadership 1, 2022-2026
Developing more accurate cardiovascular disease detection with a cellular-resolution imaging catheter.
Emerging Leadership 1, 2021-2025
Improving the Synthesis of Medical Research: The Evidence Synthesis Taxonomy Initiative.
Emerging Leadership 1, 2023-2027
Sickly sweet: managing high blood glucose during and post critical illness.
Emerging Leadership 1, 2022-2026
Preterm birth and neurodevelopment: improving long-term outcomes.
Emerging Leadership 1, 2020-2024
Increasing the value of randomised trials: a combined program of methodological and applied health research.
Emerging Leadership 1, 2025-2029
Innovative Chemoimmunotherapy for Metastatic Castration-Resistant Prostate Cancer.